Literature DB >> 18452715

Characterization of endogenous and recombinant human calpain-10.

Biao Dong1, Rihe Liu.   

Abstract

Calpain-10 is a novel ubiquitous calpain family member that has been implicated as a susceptibility gene for type 2 diabetes. One of the major challenges is that the function of calpain-10 is not yet known. To address this problem, we purified human calpain-10 from different sources, including the endogenous and the recombinant calpain-10 from HeLa S3 and 293F cells, respectively. Both endogenous and recombinant calpain-10 were present as two major forms with different origins. Interestingly, radiolabeled calpain-10 was found to be efficiently cleaved at the N-terminal region by calpain-2, but not by other proteases. None of these calpain-10 proteins have putative proteolytic activity under in vitro conditions when examined using different peptide substrates, including more than 70 in vitro translated, radiolabeled oligopeptides. Our results raise the possibility that calpain-10 may require a special intracellular localization or interacting partner(s) to acquire proteolytic activity, or it functions by interacting with other proteins rather than through its proteolytic activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452715      PMCID: PMC2556183          DOI: 10.1016/j.biochi.2008.04.001

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  35 in total

1.  Functional properties of recombinant calpain I and of mutants lacking domains III and IV of the catalytic subunit.

Authors:  E M Vilei; S Calderara; J Anagli; S Berardi; K Hitomi; M Maki; E Carafoli
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

2.  Recombinant calpain II: improved expression systems and production of a C105A active-site mutant for crystallography.

Authors:  J S Elce; C Hegadorn; S Gauthier; J W Vince; P L Davies
Journal:  Protein Eng       Date:  1995-08

3.  Purification and characterization of the active-site-mutated recombinant human mu-calpain expressed in baculovirus-infected insect cells.

Authors:  K Hitomi; Y Uchiyama; I Ohkubo; M Kunimatsu; M Sasaki; M Maki
Journal:  Biochem Biophys Res Commun       Date:  1998-05-29       Impact factor: 3.575

Review 4.  Calpain: a protease in search of a function?

Authors:  E Carafoli; M Molinari
Journal:  Biochem Biophys Res Commun       Date:  1998-06-18       Impact factor: 3.575

5.  Biologically active monomeric and heterodimeric recombinant human calpain I produced using the baculovirus expression system.

Authors:  S L Meyer; D Bozyczko-Coyne; S K Mallya; C M Spais; R Bihovsky; J K Kaywooya; D M Lang; R W Scott; R Siman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

Review 6.  Structure and physiological function of calpains.

Authors:  H Sorimachi; S Ishiura; K Suzuki
Journal:  Biochem J       Date:  1997-12-15       Impact factor: 3.857

7.  Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells.

Authors:  D L Jarvis; C Weinkauf; L A Guarino
Journal:  Protein Expr Purif       Date:  1996-09       Impact factor: 1.650

8.  Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.

Authors:  Emma Carlsson; Jenny Fredriksson; Leif Groop; Martin Ridderstråle
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  Molecular cloning and bacterial expression of cDNA for rat calpain II 80 kDa subunit.

Authors:  C I DeLuca; P L Davies; J A Samis; J S Elce
Journal:  Biochim Biophys Acta       Date:  1993-10-19

10.  Active recombinant rat calpain II. Bacterially produced large and small subunits associate both in vivo and in vitro.

Authors:  K Graham-Siegenthaler; S Gauthier; P L Davies; J S Elce
Journal:  J Biol Chem       Date:  1994-12-02       Impact factor: 5.157

View more
  2 in total

1.  Calpain-10 Activity Underlies Angiotensin II-Induced Aldosterone Production in an Adrenal Glomerulosa Cell Model.

Authors:  Mutsa Seremwe; Rick G Schnellmann; Wendy B Bollag
Journal:  Endocrinology       Date:  2015-04-02       Impact factor: 4.736

2.  Renal Biomarker and Angiostatic Mediator? Cystatin C as a Negative Regulator of Vascular Endothelial Cell Homeostasis and Angiogenesis.

Authors:  Ralf A Benndorf
Journal:  J Am Heart Assoc       Date:  2018-11-06       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.